Free Trial

Commerzbank Aktiengesellschaft FI Sells 17,208 Shares of Oracle Corporation $ORCL

Oracle logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Commerzbank Aktiengesellschaft FI trimmed its Oracle stake by 9.3% in the fourth quarter, selling 17,208 shares and ending with 167,747 shares valued at about $32.7 million.
  • Oracle’s latest results beat expectations, with EPS of $1.79 versus $1.71 expected and revenue of $17.19 billion, up 21.7% year over year. The company also guided Q4 2026 EPS to $1.96-$2.00.
  • Wall Street sentiment remains constructive: analysts now have a Moderate Buy consensus on Oracle with an average price target of $261.46, while several recent reports highlighted Oracle’s growing role in AI and cloud infrastructure.
  • Five stocks to consider instead of Oracle.

Commerzbank Aktiengesellschaft FI reduced its stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 167,747 shares of the enterprise software provider's stock after selling 17,208 shares during the period. Commerzbank Aktiengesellschaft FI's holdings in Oracle were worth $32,696,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Xponance Inc. grew its position in shares of Oracle by 1.8% in the third quarter. Xponance Inc. now owns 406,544 shares of the enterprise software provider's stock valued at $114,336,000 after purchasing an additional 7,320 shares during the last quarter. Stonegate Investment Group LLC grew its position in shares of Oracle by 3.2% in the third quarter. Stonegate Investment Group LLC now owns 99,400 shares of the enterprise software provider's stock valued at $27,955,000 after purchasing an additional 3,065 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. grew its position in shares of Oracle by 62.1% in the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 483,000 shares of the enterprise software provider's stock valued at $135,839,000 after purchasing an additional 184,996 shares during the last quarter. DDD Partners LLC acquired a new stake in shares of Oracle in the fourth quarter valued at about $1,677,000. Finally, William Blair Investment Management LLC grew its position in shares of Oracle by 28.6% in the third quarter. William Blair Investment Management LLC now owns 1,107,586 shares of the enterprise software provider's stock valued at $311,497,000 after purchasing an additional 246,243 shares during the last quarter. 42.44% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. Melius Research set a $160.00 price target on Oracle in a research report on Monday, February 9th. Arete Research set a $255.00 price target on Oracle and gave the company a "buy" rating in a research report on Thursday, May 7th. Wedbush raised their price target on Oracle from $225.00 to $275.00 and gave the company an "outperform" rating in a research report on Wednesday. TD Cowen lowered their price target on Oracle from $350.00 to $250.00 and set a "buy" rating on the stock in a research report on Friday, March 6th. Finally, Piper Sandler lowered their price target on Oracle from $240.00 to $210.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 11th. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-nine have assigned a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $261.46.

View Our Latest Stock Report on Oracle

Oracle Stock Down 1.3%

ORCL stock opened at $193.13 on Friday. Oracle Corporation has a twelve month low of $134.57 and a twelve month high of $345.72. The company has a market cap of $555.44 billion, a PE ratio of 34.67, a price-to-earnings-growth ratio of 1.87 and a beta of 1.55. The business's 50-day simple moving average is $162.96 and its 200 day simple moving average is $182.92. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 3.66.

Oracle (NYSE:ORCL - Get Free Report) last released its earnings results on Tuesday, March 10th. The enterprise software provider reported $1.79 earnings per share for the quarter, topping analysts' consensus estimates of $1.71 by $0.08. Oracle had a return on equity of 62.70% and a net margin of 25.30%.The business had revenue of $17.19 billion for the quarter, compared to the consensus estimate of $16.91 billion. During the same period last year, the business earned $1.47 earnings per share. The firm's revenue for the quarter was up 21.7% compared to the same quarter last year. Oracle has set its Q4 2026 guidance at 1.960-2.000 EPS. On average, research analysts anticipate that Oracle Corporation will post 6.08 earnings per share for the current year.

Oracle Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, April 24th. Investors of record on Thursday, April 9th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Thursday, April 9th. This represents a $2.00 dividend on an annualized basis and a yield of 1.0%. Oracle's dividend payout ratio (DPR) is 35.91%.

Insider Buying and Selling

In other Oracle news, EVP Stuart Levey sold 15,000 shares of the firm's stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $176.19, for a total transaction of $2,642,850.00. Following the completion of the transaction, the executive vice president owned 3,429 shares in the company, valued at $604,155.51. This trade represents a 81.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 40.90% of the stock is currently owned by corporate insiders.

Key Headlines Impacting Oracle

Here are the key news stories impacting Oracle this week:

  • Positive Sentiment: 24/7 Wall St. reiterated a bullish view on Oracle (ORCL), setting a 12-month price target of about $245 and pointing to strong backlog growth and accelerating cloud infrastructure economics as key upside drivers.
  • Positive Sentiment: Wedbush said Oracle is building a durable position for the next phase of the AI cycle, suggesting the market may be underestimating its role in future AI demand.
  • Positive Sentiment: Coverage focused on Oracle’s “AI heavyweight” status as investors increasingly view its legacy software base, cloud expansion, and AI infrastructure exposure as a major advantage. Oracle Went From Tech Dinosaur to AI Heavyweight
  • Positive Sentiment: Oracle also drew attention for expanding its agentic AI push through U.S. defense partnerships, reinforcing the idea that its AI platform is gaining traction in high-value government and enterprise use cases. Oracle Expands Its Agentic AI Push Through U.S. Defense Partnerships
  • Neutral Sentiment: Oracle added Cleveland Clinic CEO Tomislav Mihaljevic to its board, which may support its healthcare strategy but is unlikely to be an immediate stock-moving catalyst. Oracle adds Cleveland Clinic CEO to board of directors

About Oracle

(Free Report)

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle's product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.

Further Reading

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oracle Right Now?

Before you consider Oracle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.

While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines